AnPac Bio’s Investee Company in China Received COVID-19 Nucleic Acid Test Certification and Began Volume Tests and Collaborations with AnPac Bio
November 02, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer
October 26, 2020 06:45 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million
October 01, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Validating Approved COVID-19 Antibody Test
August 07, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Announces Preliminary Results From Prospective Trials Indicating Early-Stage Cancer Screening Effectiveness
August 04, 2020 07:30 ET
|
Anpac Bio, USA
SAN JOSE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Completed 1st Half Year with Increased ASP and Revenue
July 13, 2020 08:40 ET
|
Anpac Bio, USA
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Ranked #3 in Liquid Biopsy Clinical Samples Globally by Frost & Sullivan While Retaining #1 Position and Widening its Lead in China in Cancer Screening
June 26, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Signs a Record Multi-Million Dollar Contract for Cancer Screening
June 19, 2020 08:00 ET
|
Anpac Bio, USA
SAN JOSE, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
AnPac Bio Granted New Patent in Novel Medical Device for Disease Detection in the United States
May 11, 2020 06:46 ET
|
Anpac Bio, USA
SAN JOSE, Calif., May 11, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
APHL Applauds Obama Budget Initiative to Modernize, Speed Disease Detection
April 11, 2013 10:35 ET
|
Association of Public Health Laboratories (APHL)
SILVER SPRING, MD--(Marketwired - Apr 11, 2013) - The Association of Public Health Laboratories (APHL) applauds President Obama's $40 million budget request for the new Advanced Molecular...